Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

PMID:
10477778
[PubMed - indexed for MEDLINE]
Free Article
2.

The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.

Marchiori A, Mosena L, Prins MH, Prandoni P.

Haematologica. 2007 Aug;92(8):1107-14. Review.

PMID:
17650440
[PubMed - indexed for MEDLINE]
Free Article
3.

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.

Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW.

Arch Intern Med. 2006 Apr 10;166(7):729-36. Review.

PMID:
16606808
[PubMed - indexed for MEDLINE]
4.

Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.

Lenicek Krleza J, Jakovljevic G, Bronic A, Coen Herak D, Bonevski A, Stepan-Giljevic J, Roic G.

Pathophysiol Haemost Thromb. 2010;37(1):24-9. doi: 10.1159/000319051. Epub 2010 Jul 20. Review.

PMID:
20664190
[PubMed - indexed for MEDLINE]
5.

Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature.

Dentali F, Ageno W, Bozzato S, Malato A, Gianni M, Squizzato A, Prisco D.

J Thromb Haemost. 2012 Apr;10(4):732-7. doi: 10.1111/j.1538-7836.2012.04656.x. Review. No abstract available.

PMID:
22329698
[PubMed - indexed for MEDLINE]
6.

[Activated protein C resistance and factor V Leiden: clinical interest].

Guermazi S, Znazen R.

Pathol Biol (Paris). 2011 Oct;59(5):281-5. doi: 10.1016/j.patbio.2009.05.001. Epub 2009 Nov 6. Review. French.

PMID:
19896782
[PubMed - indexed for MEDLINE]
7.
8.

Factor V Leiden thrombophilia.

Kujovich JL.

Genet Med. 2011 Jan;13(1):1-16. doi: 10.1097/GIM.0b013e3181faa0f2. Review.

PMID:
21116184
[PubMed - indexed for MEDLINE]
9.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787
[PubMed - indexed for MEDLINE]
10.

The effect of factor V Leiden carriage on maternal and fetal health.

Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P.

CMAJ. 2002 Jul 9;167(1):48-54. Review.

PMID:
12137081
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.

Diz-Kucukkaya R, Hancer VS, Artim-Esen B, Pekcelen Y, Inanc M.

J Thromb Thrombolysis. 2010 Apr;29(3):303-9. doi: 10.1007/s11239-009-0356-9. Review.

PMID:
19504051
[PubMed - indexed for MEDLINE]
12.

Factor V Leiden: how great is the risk of venous thromboembolism?

Shaheen K, Alraies MC, Alraiyes AH, Christie R.

Cleve Clin J Med. 2012 Apr;79(4):265-72. doi: 10.3949/ccjm.79a.11072. Review.

PMID:
22473726
[PubMed - indexed for MEDLINE]
Free Article
13.

Risk assessment for recurrent venous thrombosis.

Kyrle PA, Rosendaal FR, Eichinger S.

Lancet. 2010 Dec 11;376(9757):2032-9. doi: 10.1016/S0140-6736(10)60962-2. Epub 2010 Dec 3. Review.

PMID:
21131039
[PubMed - indexed for MEDLINE]
14.

Activated protein C resistance and factor V Leiden: a review.

Rosendorff A, Dorfman DM.

Arch Pathol Lab Med. 2007 Jun;131(6):866-71. Review.

PMID:
17550313
[PubMed - indexed for MEDLINE]
15.

Acquired and congenital risk factors associated with cerebral venous sinus thrombosis.

McBane RD 2nd, Tafur A, Wysokinski WE.

Thromb Res. 2010 Aug;126(2):81-7. doi: 10.1016/j.thromres.2010.04.015. Epub 2010 Jun 11. Review.

PMID:
20541240
[PubMed - indexed for MEDLINE]
16.

Prothrombin G20210A polymorphism and thrombophilia.

Nguyen A.

Mayo Clin Proc. 2000 Jun;75(6):595-604. Review.

PMID:
10852421
[PubMed - indexed for MEDLINE]
17.

Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?

Franchini M, Lippi G.

Semin Thromb Hemost. 2011 Apr;37(3):275-9. doi: 10.1055/s-0031-1273091. Epub 2011 Mar 31. Review.

PMID:
21455861
[PubMed - indexed for MEDLINE]
18.

Management of patients with hereditary hypercoagulable disorders.

Kearon C, Crowther M, Hirsh J.

Annu Rev Med. 2000;51:169-85. Review.

PMID:
10774459
[PubMed - indexed for MEDLINE]
19.

Clinical aspects and laboratory problems in hereditary thrombophilia.

Samama M, Gerotziafas G, Conard J, Horellou M, Elalamy I.

Haemostasis. 1999;29(2-3):76-99. Review.

PMID:
10629390
[PubMed - indexed for MEDLINE]
20.

[Update thrombophilia].

Lindhoff-Last E, Luxembourg B, Pabinger I.

Hamostaseologie. 2008 Dec;28(5):365-75. Review. German.

PMID:
19132167
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk